EMERGENT BIOSOLUTIONS INC. Interest Expense
EMERGENT BIOSOLUTIONS INC. (EBS) reported Interest Expense of $24.30 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-02
- EMERGENT BIOSOLUTIONS INC. interest expense for the quarter ending 2024-03-31 was $24.30M, a 35.75% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. interest expense for the quarter ending 2023-12-31 was $21.70M, a 69.53% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. interest expense for the quarter ending 2023-09-30 was $19.70M, a 131.76% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. interest expense for the quarter ending 2023-06-30 was $28.60M, a 266.67% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. interest expense for fiscal 2023 was $87.90M, a 135.66% increase from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. interest expense for fiscal 2022 was $37.30M, a 8.12% increase from fiscal 2021.
- EMERGENT BIOSOLUTIONS INC. interest expense for fiscal 2021 was $34.50M, a 10.22% increase from fiscal 2020.
- EMERGENT BIOSOLUTIONS INC. interest expense for fiscal 2020 was $31.30M, a 18.49% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $24.30M 10-Q · filed 2024-05-02 | $46.00M derived: sum of 2 quarters · filed 2024-05-02 | $65.70M derived: sum of 3 quarters · filed 2024-05-02 | $94.30M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2023-12-31 | $21.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $41.40M derived: sum of 2 quarters · filed 2024-03-08 | $70.00M derived: sum of 3 quarters · filed 2024-03-08 | $87.90M 10-K · filed 2024-03-08 | ||||
| 2023-09-30 | $19.70M 10-Q · filed 2023-12-11 | $48.30M derived: sum of 2 quarters · filed 2023-12-11 | $66.20M 10-Q · filed 2023-12-11 | $79.00M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2023-06-30 | $28.60M 10-Q · filed 2023-08-09 | $46.50M 10-Q · filed 2023-08-09 | $59.30M derived: sum of 3 quarters · filed 2024-05-02 | $67.80M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2023-03-31 | $17.90M 10-Q · filed 2024-05-02 | $30.70M derived: sum of 2 quarters · filed 2024-05-02 | $39.20M derived: sum of 3 quarters · filed 2024-05-02 | $47.00M derived: sum of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $21.30M derived: sum of 2 quarters · filed 2024-03-08 | $29.10M derived: sum of 3 quarters · filed 2024-03-08 | $37.30M 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | $8.50M 10-Q · filed 2023-12-11 | $16.30M derived: sum of 2 quarters · filed 2023-12-11 | $24.50M 10-Q · filed 2023-12-11 | $33.50M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-06-30 | $7.80M 10-Q · filed 2023-08-09 | $16.00M 10-Q · filed 2023-08-09 | $25.00M derived: sum of 3 quarters · filed 2024-03-08 | $33.40M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | $8.20M 10-Q · filed 2023-05-10 | $17.20M derived: sum of 2 quarters · filed 2024-03-08 | $25.60M derived: sum of 3 quarters · filed 2024-03-08 | $34.20M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $17.40M derived: sum of 2 quarters · filed 2024-03-08 | $26.00M derived: sum of 3 quarters · filed 2024-03-08 | $34.50M 10-K · filed 2024-03-08 | ||||
| 2021-09-30 | $8.40M 10-Q · filed 2022-11-09 | $17.00M derived: sum of 2 quarters · filed 2022-11-09 | $25.50M 10-Q · filed 2022-11-09 | $34.20M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-06-30 | $8.60M 10-Q · filed 2022-08-02 | $17.10M 10-Q · filed 2022-08-02 | $25.80M derived: sum of 3 quarters · filed 2023-12-11 | $33.40M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-03-31 | $8.50M 10-Q · filed 2022-04-29 | $17.20M derived: sum of 2 quarters · filed 2023-12-11 | $24.80M derived: sum of 3 quarters · filed 2023-12-11 | $31.20M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2020-12-31 | $8.70M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $16.30M derived: sum of 2 quarters · filed 2023-12-11 | $22.70M derived: sum of 3 quarters · filed 2023-12-11 | $31.30M 10-K/A · filed 2023-12-11 | ||||
| 2020-09-30 | $7.60M 10-Q · filed 2021-11-05 | $14.00M derived: sum of 2 quarters · filed 2021-11-05 | $22.60M 10-Q · filed 2021-11-05 | $31.70M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $6.40M 10-Q · filed 2021-07-30 | $15.00M 10-Q · filed 2021-07-30 | $24.10M derived: sum of 3 quarters · filed 2022-02-25 | $34.40M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $8.60M 10-Q · filed 2021-04-30 | $17.70M derived: sum of 2 quarters · filed 2022-02-25 | $28.00M derived: sum of 3 quarters · filed 2022-02-25 | $37.50M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $19.40M derived: sum of 2 quarters · filed 2022-02-25 | $28.90M derived: sum of 3 quarters · filed 2022-02-25 | $38.40M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $10.30M 10-Q · filed 2020-11-06 | $19.80M derived: sum of 2 quarters · filed 2020-11-06 | $29.30M 10-Q · filed 2020-11-06 | $37.50M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $9.50M 10-Q · filed 2020-07-31 | $19.00M 10-Q · filed 2020-07-31 | $27.20M derived: sum of 3 quarters · filed 2021-02-19 | $27.80M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $9.60M 10-Q · filed 2020-05-01 | $17.70M derived: sum of 2 quarters · filed 2021-02-19 | $18.30M derived: sum of 3 quarters · filed 2021-02-19 | $19.30M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $8.70M derived: sum of 2 quarters · filed 2021-02-19 | $9.70M derived: sum of 3 quarters · filed 2021-02-19 | $9.90M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $600.00K 10-Q · filed 2019-11-07 | $642.00K 10-Q · filed 2018-11-02 | $1.60M derived: sum of 2 quarters · filed 2019-11-07 | $1.80M 10-Q · filed 2019-11-07 | $1.88M 10-Q · filed 2018-11-02 | $2.67M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $1.00M 10-Q · filed 2019-08-02 | $1.01M 10-Q · filed 2018-08-03 | $1.20M 10-Q · filed 2019-08-02 | $1.24M 10-Q · filed 2018-08-03 | $2.07M derived: sum of 3 quarters · filed 2020-02-25 | $4.06M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $200.00K 10-Q · filed 2019-05-08 | $234.00K 10-Q · filed 2018-05-04 | $1.07M derived: sum of 2 quarters · filed 2020-02-25 | $3.06M derived: sum of 3 quarters · filed 2020-02-25 | $4.86M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $866.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $2.86M derived: sum of 2 quarters · filed 2020-02-25 | $4.66M derived: sum of 3 quarters · filed 2020-02-25 | $6.60M 10-K · filed 2020-02-25 | $6.59M 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $1.99M 10-Q · filed 2018-11-02 | $3.80M derived: sum of 2 quarters · filed 2018-11-02 | $5.73M 10-Q · filed 2018-11-02 | $8.25M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-06-30 | $1.80M 10-Q · filed 2018-08-03 | $3.74M 10-Q · filed 2018-08-03 | $6.26M derived: sum of 3 quarters · filed 2019-02-22 | $8.31M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-03-31 | $1.94M 10-Q · filed 2018-05-04 | $4.46M derived: sum of 2 quarters · filed 2019-02-22 | $6.50M derived: sum of 3 quarters · filed 2019-02-22 | $8.02M derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $4.57M derived: sum of 2 quarters · filed 2019-02-22 | $6.08M derived: sum of 3 quarters · filed 2019-02-22 | $7.60M 10-K · filed 2019-02-22 | $7.62M 10-K · filed 2017-02-28 | |||
| 2016-09-30 | $2.05M 10-Q · filed 2017-11-03 | $3.56M derived: sum of 2 quarters · filed 2017-11-03 | $5.08M 10-Q · filed 2017-11-03 | $6.68M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $1.51M 10-Q · filed 2017-08-04 | $1.51M 10-Q · filed 2016-08-05 | $3.03M 10-Q · filed 2017-08-04 | $4.63M derived: sum of 3 quarters · filed 2018-02-23 | $6.27M derived: sum of 4 quarters · filed 2018-02-23 | |||
| 2016-03-31 | $1.52M 10-Q · filed 2017-05-05 | $3.12M derived: sum of 2 quarters · filed 2018-02-23 | $4.76M derived: sum of 3 quarters · filed 2018-02-23 | $6.39M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2015-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $3.23M derived: sum of 2 quarters · filed 2018-02-23 | $4.86M derived: sum of 3 quarters · filed 2018-02-23 | $6.52M 10-K · filed 2018-02-23 | ||||
| 2015-09-30 | $1.64M 10-Q · filed 2016-11-09 | $3.26M derived: sum of 2 quarters · filed 2016-11-09 | $4.92M 10-Q · filed 2016-11-09 | $6.10M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $1.63M 10-Q · filed 2016-08-05 | $3.29M 10-Q · filed 2016-08-05 | $4.46M derived: sum of 3 quarters · filed 2017-02-28 | $6.27M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $1.66M 10-Q · filed 2016-05-06 | $2.83M derived: sum of 2 quarters · filed 2017-02-28 | $4.64M derived: sum of 3 quarters · filed 2017-02-28 | $6.37M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $2.98M derived: sum of 2 quarters · filed 2017-02-28 | $4.71M derived: sum of 3 quarters · filed 2017-02-28 | $8.24M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $1.81M 10-Q · filed 2015-11-06 | $3.53M derived: sum of 2 quarters · filed 2015-11-06 | $7.07M 10-Q · filed 2015-11-06 | $7.05M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $1.72M 10-Q · filed 2015-08-06 | $5.26M 10-Q · filed 2015-08-06 | $5.24M derived: sum of 3 quarters · filed 2016-02-29 | $5.24M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $3.54M 10-Q · filed 2015-05-08 | $3.52M derived: sum of 2 quarters · filed 2016-02-29 | $3.52M derived: sum of 3 quarters · filed 2016-02-29 | $3.52M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$14.00K derived: sum of 2 quarters · filed 2016-02-29 | -$11.00K derived: sum of 3 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 | $3.00K derived: sum of 2 quarters · filed 2014-11-10 | $14.00K 10-Q · filed 2014-11-10 | $20.00K derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | $3.00K 10-Q · filed 2014-08-08 | $14.00K 10-Q · filed 2014-08-08 | $20.00K derived: sum of 3 quarters · filed 2015-03-09 | $20.00K derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | $11.00K 10-Q · filed 2014-05-12 | $17.00K derived: sum of 2 quarters · filed 2015-03-09 | $17.00K derived: sum of 3 quarters · filed 2015-03-09 | $17.00K derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $6.00K derived: sum of 2 quarters · filed 2015-03-09 | $6.00K derived: sum of 3 quarters · filed 2015-03-09 | $6.00K 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-11-08 | $0.00 10-Q · filed 2013-11-08 | $3.00K derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-06 | $6.00K 10-Q · filed 2013-08-06 | $3.00K derived: sum of 3 quarters · filed 2014-03-10 | $3.00K derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-03-31 | $3.00K 10-Q · filed 2013-05-03 | $3.00K derived: sum of 2 quarters · filed 2014-03-10 | $3.00K derived: sum of 3 quarters · filed 2014-03-10 | $9.00K derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $0.00 derived: sum of 2 quarters · filed 2014-03-10 | $6.00K derived: sum of 3 quarters · filed 2014-03-10 | $0.00 10-K · filed 2014-03-10 | ||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-01 | $6.00K derived: sum of 2 quarters · filed 2012-11-01 | $0.00 10-Q · filed 2012-11-01 | $6.00K derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2011-06-30 | $6.00K 10-Q · filed 2012-08-03 | $6.00K 10-Q · filed 2012-08-03 | $6.00K derived: sum of 3 quarters · filed 2013-03-08 | $6.00K derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-04 | $0.00 derived: sum of 2 quarters · filed 2013-03-08 | $0.00 derived: sum of 3 quarters · filed 2013-03-08 | $2.00K derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $0.00 derived: sum of 2 quarters · filed 2013-03-08 | $2.00K derived: sum of 3 quarters · filed 2013-03-08 | $0.00 10-K · filed 2013-03-08 | ||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-04 | $2.00K derived: sum of 2 quarters · filed 2011-11-04 | $0.00 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $2.00K 10-Q · filed 2011-08-05 | $7.00K 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $7.00K 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |